Wednesday, FDA released a letter stating how the agency intends to implement the scope of orphan drug exclusivity awarded to Eagle Pharmaceuticals’ Bendeka (bendamustine HCl) by the D.C. Circuit Court ...
Before you start treatment with Bendeka, tell your doctor and pharmacist which prescription, over-the-counter, and other medications you take. By sharing this information with them, you may help ...
New Strength for Nuvigil Launched Teva announced that Bendeka (bendamustine HCl) Injection is now available to replace Treanda (bendamustine HCl) Injection. Teva announced that Bendeka (bendamustine ...
In the first quarter of 2016, Teva Pharmaceutical Industries (TEVA) launched a new drug, Bendeka, in partnership with Eagle Pharmaceuticals. The new drug is expected to allow Teva to maintain its ...
WOODCLIFF LAKE, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that it has reached a settlement agreement with Hospira, ...
Eagle has reached a settlement agreement with Dr. Reddy’s. Eagle had asserted its Orange Book-listed patents against Dr. Reddy’s related to its new drug application referencing Bendeka. Bendeka is ...
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) announced today that the U.S. Food and Drug Administration (FDA) has granted seven years of ...
WOODCLIFF LAKE, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has entered into a royalty purchase agreement ...
Image source: Flickr user Steve Jurvetson. Continue Reading Below What:News of a positive court decision that could support sales growth led to shares in Eagle Pharmaceuticals spiking 27.8% earlier ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved a low-volume bendamustine hydrochloride injection for the treatment of patients with chronic ...
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) (“Eagle” or the “Company”) announced today that the U.S. Food and Drug Administration (FDA) has denied Eagle’s request ...
In the first quarter of 2016, Teva Pharmaceutical Industries (TEVA) launched a new drug, Bendeka, in partnership with Eagle Pharmaceuticals. The new drug is expected to allow Teva to maintain its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results